Overexpression of CXCR1/CXCR2 on mesenchymal stromal cells may be an effective treatment for acute myocardial infarction

By Xu Jianzhong   Chen Qizhi   Shi Chunzhi   Yin Zhaofang  

Cytotherapy, Vol. 11, Iss. 8, 2009-11 ,pp. : 990-991

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Intramyocardial and intracoronary autologous bone marrow-derived mesenchymal stromal cell treatment in chronic severe dilated cardiomyopathy

By Chin Sze-Piaw   Poey Alfred C.   Wong Chee-Yin   Chang Sau-Kong   Tan Chiang-Soo   Ng Mei-Theng   Chew Kee-Hock   Lam Kai-Huat   Cheong Soon-Keng  

Cytotherapy, Vol. 13, Iss. 7, 2011-08 ,pp. : 814-821

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Characterization of bone marrow-derived mesenchymal stromal cells (MSC) based on gene expression profiling of functionally defined MSC subsets

By Tormin Ariane   Brune Jan   Olsson Eleonor   Valcich Jeanette   Neuman Ulf   Olofsson Tor   Jacobsen Sten-Eirik   Scheding Stefan  

Cytotherapy, Vol. 11, Iss. 2, 2009-04 ,pp. : 114-128

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Comparison of chemokine and receptor gene expression between Wharton's jelly and bone marrow-derived mesenchymal stromal cells

By Balasubramanian Sudha   Venugopal Parvathy   Sundarraj Swathi   Zakaria Zubaidah   Majumdar Anish Sen   Ta Malancha  

Cytotherapy, Vol. 14, Iss. 1, 2012-01 ,pp. : 26-33

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Growth factor and cytokine expression of human mesenchymal stromal cells is not altered in an in vitro model of tissue damage

By Montzka Katrin   Führmann Tobias   Müller-Ehmsen Jochen   Wöltje Michael   Brook Gary A.  

Cytotherapy, Vol. 12, Iss. 7, 2010-11 ,pp. : 870-880

Ashgate Publishing Ltd

Access to resources Recommend Favorite